Labgenomics Usa Llc Acquires Qdx Pathology In A Strategic Move To Expand Its Diagnostic Lab Services And Ivd Diagnostic Products Business Into The Us Market
Acquiring Company
LabGenomics Ltd
Acquired Company
QDx Pathology
South KoreaBiotechnologyHealth CareMedicalGeneticsHealth DiagnosticsBiotechnologyHealth CareMedicalDescription
LabGenomics USA, a subsidiary of LabGenomics Co., Ltd., announced its acquisition of QDx Pathology, a leader in molecular and diagnostic pathology. The acquisition is expected to have significant implications for the future of both companies and the industry.
Quick answer
LabGenomics Ltd is acquiring QDx Pathology, announced September 5, 2023. LabGenomics Ltd is based in South Korea.
- How much did LabGenomics Ltd pay for QDx Pathology?
- The deal value was not disclosed.
- What does LabGenomics Ltd do?
- LabGenomics (KOSDAQ:084650) is a healthcare company specializing in molecular diagnostics leading the sector for 21 years.
- Where are LabGenomics Ltd and QDx Pathology based?
- LabGenomics Ltd is based in South Korea.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Genetics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Airlife Completes Acquisition Of Avanos Medical’S Respiratory Health Business (October 2, 2023)
- Lilly To Acquire Point Biopharma To Expand Oncology Capabilities Into Next-Generation Radioligand Therapies (October 3, 2023)
- Scilex Holding Company Announces The Consummation Of The Previously Announced Purchase Of All Of The Scilex Common Shares, Preferred Shares And Warrants Owned By Sorrento Therapeutics, Inc. (September 21, 2023)
- Caldera Medical Acquires Atlantic Therapeutics To Expand Portfolio In Women’S Health (September 6, 2023)
- Rqm+™ Acquires Germany Based Cro Kottmann (August 28, 2023)
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
Who to call at LabGenomics Ltd, and when
When LabGenomics Ltd changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day LabGenomics Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at LabGenomics Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at LabGenomics Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment LabGenomics Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired QDx Pathology?
QDx Pathology was acquired by LabGenomics Ltd, based in South Korea. The deal was reported on September 5, 2023. LabGenomics (KOSDAQ:084650) is a healthcare company specializing in molecular diagnostics leading the sector for 21 years. LabGenomics Ltd is privately held and operates in Biotechnology.
When did LabGenomics Ltd acquire QDx Pathology?
LabGenomics Ltd's acquisition of QDx Pathology was reported on September 5, 2023. LabGenomics USA, a subsidiary of LabGenomics Co., Ltd., announced its acquisition of QDx Pathology, a leader in molecular and diagnostic pathology. The acquisition is expected to have significant implications for the future of both companies and the industry. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does QDx Pathology do?
QDx Pathology Services is a national, independent, full-service molecular and anatomical pathology laboratory dedicated to providing diagnostic excellence to our customers and their patients. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.